In a patient with hypertension, depression, and generalized anxiety who cannot tolerate paroxetine, what medication should be used next?

Switch to Sertraline or Escitalopram as Next-Line SSRI

For a patient with hypertension, depression, and generalized anxiety disorder who cannot tolerate paroxetine, the best next medication is either sertraline or escitalopram, as these SSRIs have better tolerability profiles and are effective for both depression and anxiety while being safe in hypertensive patients. 1, 2

Rationale for Within-Class SSRI Switch

When paroxetine is not tolerated, switching to another SSRI is the most evidence-based approach:

• Sertraline is specifically recommended for older patients and those with medical comorbidities due to fewer drug interactions and better tolerability 1
• Escitalopram is well-tolerated with lower anticholinergic effects than paroxetine 3, 1
• Citalopram treatment of paroxetine-intolerant patients showed 87% completion rate with only 10% dropout due to adverse events, and side effects that were intolerable with paroxetine recurred less than 30% of the time 2

Why These SSRIs Over Paroxetine

Paroxetine has specific disadvantages that sertraline and escitalopram avoid:

• More anticholinergic effects than other SSRIs 3, 1
• Higher discontinuation rates due to adverse effects 1
• Sertraline has "less effect on metabolism of other medications" compared to other SSRIs 3

Addressing All Three Conditions

Both depression and generalized anxiety disorder require treatment, and SSRIs address both:

• SSRIs are first-line for both MDD and GAD 4, 5, 6, 7
• Venlafaxine (SNRI) is an alternative but has "slightly higher risks of discontinuation compared with SSRIs" and can cause blood pressure increases 8, 1
• Avoid venlafaxine in hypertensive patients as it "should be prescribed with caution in patients with cardiac disease" and "blood pressure increases can occur" 8

Hypertension Management Considerations

The patient's hypertension should not be affected by SSRI choice:

• SSRIs do not significantly affect blood pressure 8
• Continue standard antihypertensive therapy per guidelines: ACE inhibitor/ARB, CCB, or thiazide diuretic as first-line 9, 10
• Beta-blockers are NOT first-line for uncomplicated hypertension unless there are other indications 10

Dosing Algorithm

Start with:

• Sertraline 25-50 mg daily (can increase to 200 mg/day) 3
• OR Escitalopram 10 mg daily (can increase to 20 mg/day) 1

Titration:

• Assess response at 1-2 weeks 11
• If inadequate response at 6-8 weeks, increase dose or consider switching 11
• Full therapeutic trial requires 4-8 weeks at adequate dose 3

If SSRIs Continue to Fail

Second-line options for treatment-resistant cases:

1. Cognitive behavioral therapy (CBT) - can be added to medication or used as monotherapy 12, 13, 7
2. Buspirone augmentation - specifically for anxiety symptoms 3, 6
3. Mirtazapine - "potent and well tolerated; promotes sleep" 3, useful if insomnia is prominent
4. Duloxetine - effective for both depression and anxiety, though monitor blood pressure 8

Common Pitfalls to Avoid

• Do not use benzodiazepines as monotherapy - only appropriate for short-term adjunctive use 5, 6, 7
• Do not combine two SSRIs - switch, don't add 10
• Do not use tricyclic antidepressants first-line in hypertensive patients due to cardiac toxicity concerns 8
• Ensure adequate trial duration - at least 4-8 weeks at therapeutic dose before declaring treatment failure 3, 11
• Continue treatment 4-9 months after remission for first episode, longer for recurrent depression 1, 11